JP2017080507A5 - - Google Patents

Download PDF

Info

Publication number
JP2017080507A5
JP2017080507A5 JP2017003854A JP2017003854A JP2017080507A5 JP 2017080507 A5 JP2017080507 A5 JP 2017080507A5 JP 2017003854 A JP2017003854 A JP 2017003854A JP 2017003854 A JP2017003854 A JP 2017003854A JP 2017080507 A5 JP2017080507 A5 JP 2017080507A5
Authority
JP
Japan
Prior art keywords
pharmaceutical preparation
cells
administered
suspension
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017003854A
Other languages
English (en)
Japanese (ja)
Other versions
JP6382360B2 (ja
JP2017080507A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017080507A publication Critical patent/JP2017080507A/ja
Publication of JP2017080507A5 publication Critical patent/JP2017080507A5/ja
Application granted granted Critical
Publication of JP6382360B2 publication Critical patent/JP6382360B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2017003854A 2004-03-22 2017-01-13 間葉幹細胞及びその使用法 Expired - Lifetime JP6382360B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55511804P 2004-03-22 2004-03-22
US60/555,118 2004-03-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012058539A Division JP6114500B2 (ja) 2004-03-22 2012-03-15 間葉幹細胞及びその使用法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017155229A Division JP6757300B2 (ja) 2004-03-22 2017-08-10 間葉幹細胞及びその使用法

Publications (3)

Publication Number Publication Date
JP2017080507A JP2017080507A (ja) 2017-05-18
JP2017080507A5 true JP2017080507A5 (enExample) 2017-08-31
JP6382360B2 JP6382360B2 (ja) 2018-08-29

Family

ID=46060822

Family Applications (8)

Application Number Title Priority Date Filing Date
JP2012058539A Expired - Lifetime JP6114500B2 (ja) 2004-03-22 2012-03-15 間葉幹細胞及びその使用法
JP2014241859A Expired - Lifetime JP5997237B2 (ja) 2004-03-22 2014-11-28 間葉幹細胞及びその使用法
JP2017003854A Expired - Lifetime JP6382360B2 (ja) 2004-03-22 2017-01-13 間葉幹細胞及びその使用法
JP2017155229A Expired - Lifetime JP6757300B2 (ja) 2004-03-22 2017-08-10 間葉幹細胞及びその使用法
JP2018190636A Expired - Lifetime JP6757383B2 (ja) 2004-03-22 2018-10-09 間葉幹細胞及びその使用法
JP2020047240A Expired - Lifetime JP7033159B2 (ja) 2004-03-22 2020-03-18 間葉幹細胞及びその使用法
JP2021140167A Expired - Lifetime JP7546239B2 (ja) 2004-03-22 2021-08-30 間葉幹細胞及びその使用法
JP2023023996A Pending JP2023065486A (ja) 2004-03-22 2023-02-20 間葉幹細胞及びその使用法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2012058539A Expired - Lifetime JP6114500B2 (ja) 2004-03-22 2012-03-15 間葉幹細胞及びその使用法
JP2014241859A Expired - Lifetime JP5997237B2 (ja) 2004-03-22 2014-11-28 間葉幹細胞及びその使用法

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2017155229A Expired - Lifetime JP6757300B2 (ja) 2004-03-22 2017-08-10 間葉幹細胞及びその使用法
JP2018190636A Expired - Lifetime JP6757383B2 (ja) 2004-03-22 2018-10-09 間葉幹細胞及びその使用法
JP2020047240A Expired - Lifetime JP7033159B2 (ja) 2004-03-22 2020-03-18 間葉幹細胞及びその使用法
JP2021140167A Expired - Lifetime JP7546239B2 (ja) 2004-03-22 2021-08-30 間葉幹細胞及びその使用法
JP2023023996A Pending JP2023065486A (ja) 2004-03-22 2023-02-20 間葉幹細胞及びその使用法

Country Status (5)

Country Link
JP (8) JP6114500B2 (enExample)
AT (1) ATE556134T1 (enExample)
CA (3) CA2868733C (enExample)
ES (7) ES2385450T3 (enExample)
TR (1) TR201901268T4 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2564679C (en) * 2004-03-22 2015-06-23 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
ES2385450T3 (es) * 2004-03-22 2012-07-25 Osiris Therapeutics, Inc. Células madre mesenquimatosas y sus utilizaciones
US20150110751A1 (en) * 2012-05-16 2015-04-23 Kennedy Krieger Institute, Inc. Stem cells as an individualized maternal therapy for prevention of prematurity
JP2016210730A (ja) * 2015-05-08 2016-12-15 上田　実 医薬組成物及びその製造方法並びに医薬品
EP3543331A4 (en) 2016-11-15 2020-07-01 Kaneka Corporation CELL POPULATION CONTAINING MESENCHYMAL STEM CELLS DERIVED FROM F RATE APPENDICES, METHOD FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION
WO2019102268A1 (en) 2017-11-22 2019-05-31 Mesoblast International Sarl Cellular compositions and methods of treatment i
JP7454379B2 (ja) 2017-12-28 2024-03-22 株式会社カネカ 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物
US12702683B2 (en) 2019-01-03 2026-08-11 Mesoblast International Sárl Method for improving visual acuity
WO2020251020A1 (ja) 2019-06-14 2020-12-17 株式会社カネカ 間葉系細胞を含む細胞集団、それを含む医薬組成物、及び、その製造方法
WO2021028583A1 (en) * 2019-08-15 2021-02-18 Nextcell Pharma Ab Allogeneic composition for treatment of cns disorders
WO2021176001A1 (en) 2020-03-05 2021-09-10 Mesoblast International Sàrl Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
CN113813288B (zh) * 2021-08-11 2024-02-13 谢岩 间充质干细胞及包含其的组合物用于制备治疗烧伤难愈创面的药物的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651641B2 (ja) * 1983-08-29 1994-07-06 株式会社ミドリ十字 ガンマ・インターフェロン組成物
WO1987005518A1 (en) * 1986-03-17 1987-09-24 Schering Corporation Treatment of cancers with gamma interferon
CA2191733A1 (en) * 1994-06-07 1995-12-21 Daniel A. Vallera Methods for inhibiting antigen specific t cell responses
JP2000508922A (ja) * 1996-04-26 2000-07-18 ケース ウエスターン リザーブ ユニバーシティ 間葉幹細胞を用いる皮膚再生
WO1999047163A2 (en) * 1998-03-18 1999-09-23 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6368636B1 (en) * 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
JP2002510655A (ja) * 1998-04-03 2002-04-09 オシリス セラピューティクス，インコーポレイテッド 免疫抑制剤としての間葉幹細胞によるｔ細胞応答を阻害する方法とその利用
AU2925401A (en) * 2000-01-19 2001-07-31 Parkash S Gill Methods and compositions for antisense vegf oligonucleotides
WO2001080865A2 (en) * 2000-04-25 2001-11-01 Osiris Therapeutics, Inc. Joint repair using mesenchymal stem cells
MXPA04007426A (es) * 2002-02-01 2004-10-11 Schering Corp Usos de citosina de mamifero; reactivos relacionados.
JP3897343B2 (ja) * 2002-08-01 2007-03-22 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
US20040258670A1 (en) * 2002-12-05 2004-12-23 Case Western Reserve University Cell-based therapies for ischemia
CA2564679C (en) * 2004-03-22 2015-06-23 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
ES2385450T3 (es) * 2004-03-22 2012-07-25 Osiris Therapeutics, Inc. Células madre mesenquimatosas y sus utilizaciones

Similar Documents

Publication Publication Date Title
JP2018009002A5 (enExample)
Li et al. Role of interleukin-17 in acute pancreatitis
Tetè et al. IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation
JP2009543579A5 (enExample)
Mohammadian et al. Effect of bone marrow derived mesenchymal stem cells on lung pathology and inflammation in ovalbumin-induced asthma in mouse
RU2014137321A (ru) ГИСТИДИЛ-тРНК-СИНТЕТАЗЫ ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ
CN104884076A (zh) 利用了hmgb1片段的新型心肌梗塞的治疗方法
JP2018526447A5 (enExample)
JP2013544244A5 (enExample)
JP2019208513A5 (enExample)
JP2012506394A5 (enExample)
Oka et al. The acquisition of trisomy 8 associated with Behçet's-like disease in myelodysplastic syndrome
HRP20240798T1 (hr) Terapija matičnim stanicama kod patologija endometrija
JP2009544690A5 (enExample)
JP2014513126A5 (enExample)
Li et al. The pivotal role of cytokines in liver disease pathogenesis and therapeutic potential
CN103284988A (zh) 炔丙基半胱氨酸及其类似物在制备治疗免疫相关炎症疾病药物中的用途
JP2017516832A5 (enExample)
JP2008512491A5 (enExample)
JP2013510905A5 (enExample)
CN114984011A (zh) 吡咯并吡啶类化合物在制备治疗狼疮药物中的应用
RU2016118228A (ru) Способы уменьшения кахексии, связанной с раком
JP2020518588A5 (enExample)
JP2016504311A5 (enExample)
JP2014521675A5 (enExample)